Vita Life Sciences Ltd Total Liabilities
Vita Life Sciences Ltd total liabilities. Based on the latest financial reports, Vita Life Sciences Ltd (VLS) has total liabilities worth AU$22.03 Million AUD (≈ $15.59 Million USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check how resilient are Vita Life Sciences Ltd's assets to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Vita Life Sciences Ltd (2000–2024)
Total liabilities of Vita Life Sciences Ltd from 2000 to 2024. This chart illustrates how Vita Life Sciences Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore Vita Life Sciences Ltd long-term investment intensity to see how much of total assets are deployed in long-term investments.
Vita Life Sciences Ltd Competitors by Total Liabilities
The table below lists competitors of Vita Life Sciences Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Fortune Oriental Co Ltd
TW:2491
|
Taiwan | NT$273.98 Million |
|
Bank of the James Financial Group
NASDAQ:BOTJ
|
USA | $979.90 Million |
|
Organogenesis Holdings Inc
NASDAQ:ORGO
|
USA | $123.85 Million |
|
Yen Sun Technology
TWO:6275
|
Taiwan | NT$2.13 Billion |
|
Optical Cable Corporation
NASDAQ:OCC
|
USA | $20.58 Million |
|
Shimmick Corporation Common Stock
NASDAQ:SHIM
|
USA | $275.26 Million |
|
Inovio Pharmaceuticals Inc
NASDAQ:INO
|
USA | $77.11 Million |
|
Faraday Future Intelligent Electric Inc
NASDAQ:FFIE
|
USA | $339.87 Million |
Liability Composition Analysis (2000–2024)
This chart breaks down Vita Life Sciences Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Vita Life Sciences Ltd balance sheet assets.
Liquidity & Leverage Metrics
Vita Life Sciences Ltd Total Liabilities Ratios Explained
Vita Life Sciences Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.94 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | 1.46 | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.42 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.30 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Vita Life Sciences Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Vita Life Sciences Ltd (2000–2024)
The table below shows the annual total liabilities of Vita Life Sciences Ltd from 2000 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | AU$19.61 Million ≈ $13.87 Million |
+19.02% |
| 2023-12-31 | AU$16.48 Million ≈ $11.66 Million |
+7.71% |
| 2022-12-31 | AU$15.30 Million ≈ $10.82 Million |
+3.02% |
| 2021-12-31 | AU$14.85 Million ≈ $10.51 Million |
+1.27% |
| 2020-12-31 | AU$14.66 Million ≈ $10.37 Million |
+4.88% |
| 2019-12-31 | AU$13.98 Million ≈ $9.89 Million |
+5.00% |
| 2018-12-31 | AU$13.31 Million ≈ $9.42 Million |
+63.13% |
| 2017-12-31 | AU$8.16 Million ≈ $5.77 Million |
-11.14% |
| 2016-12-31 | AU$9.18 Million ≈ $6.50 Million |
-3.45% |
| 2015-12-31 | AU$9.51 Million ≈ $6.73 Million |
+9.26% |
| 2014-12-31 | AU$8.71 Million ≈ $6.16 Million |
+51.67% |
| 2013-12-31 | AU$5.74 Million ≈ $4.06 Million |
+4.92% |
| 2012-12-31 | AU$5.47 Million ≈ $3.87 Million |
+24.54% |
| 2011-12-31 | AU$4.39 Million ≈ $3.11 Million |
-31.17% |
| 2010-12-31 | AU$6.38 Million ≈ $4.52 Million |
+30.01% |
| 2009-12-31 | AU$4.91 Million ≈ $3.47 Million |
+2.38% |
| 2008-12-31 | AU$4.79 Million ≈ $3.39 Million |
+24.56% |
| 2007-12-31 | AU$3.85 Million ≈ $2.72 Million |
-58.89% |
| 2006-12-31 | AU$9.36 Million ≈ $6.62 Million |
-68.51% |
| 2005-12-31 | AU$29.73 Million ≈ $21.04 Million |
+1.80% |
| 2004-12-31 | AU$29.21 Million ≈ $20.67 Million |
+0.97% |
| 2003-12-31 | AU$28.92 Million ≈ $20.47 Million |
+39.80% |
| 2002-12-31 | AU$20.69 Million ≈ $14.64 Million |
-20.03% |
| 2001-12-31 | AU$25.87 Million ≈ $18.30 Million |
+29.32% |
| 2000-12-31 | AU$20.00 Million ≈ $14.15 Million |
-- |
About Vita Life Sciences Ltd
Vita Life Sciences Limited, a healthcare company, engages in formulating, packaging, distributing, and selling vitamins and supplements in Australia, Singapore, Malaysia, Thailand, Vietnam, Indonesia, and China. The company offers various minerals, herbs, and superfoods. It markets its products through pharmacies and health food channels under the Herbs of Gold, VitaHealth, and VitaScience brands… Read more